Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Therapeutic potential of thymosin β4 in myocardial infarct and heart failure.

Stark C, Taimen P, Tarkia M, Pärkkä J, Saraste A, Alastalo TP, Savunen T, Koskenvuo J.

Ann N Y Acad Sci. 2012 Oct;1269:117-24. doi: 10.1111/j.1749-6632.2012.06695.x.

PMID:
23045979
[PubMed - indexed for MEDLINE]
2.
3.

Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.

Hinkel R, Trenkwalder T, Kupatt C.

Ann N Y Acad Sci. 2012 Oct;1269:102-9. doi: 10.1111/j.1749-6632.2012.06693.x.

PMID:
23045977
[PubMed - indexed for MEDLINE]
4.

Cardiac repair with thymosin β4 and cardiac reprogramming factors.

Srivastava D, Ieda M, Fu J, Qian L.

Ann N Y Acad Sci. 2012 Oct;1270:66-72. doi: 10.1111/j.1749-6632.2012.06696.x.

PMID:
23050819
[PubMed - indexed for MEDLINE]
5.

Thymosin beta4 and Ac-SDKP: tools to mend a broken heart.

Rossdeutsch A, Smart N, Riley PR.

J Mol Med (Berl). 2008 Jan;86(1):29-35. Epub 2007 Aug 15. Review.

PMID:
17701149
[PubMed - indexed for MEDLINE]
6.

Thymosin beta4 and cardiac repair.

Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I.

Ann N Y Acad Sci. 2010 Apr;1194:87-96. doi: 10.1111/j.1749-6632.2010.05468.x.

PMID:
20536454
[PubMed - indexed for MEDLINE]
7.

Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.

Chiu LL, Reis LA, Momen A, Radisic M.

Regen Med. 2012 Jul;7(4):523-33. doi: 10.2217/rme.12.35.

PMID:
22817626
[PubMed - indexed for MEDLINE]
8.

[Biotechnological production of acetylated thymosin beta4].

Beĭrakhova KA, Stepanenko VN, Miroshnikov AI, Esipov RS.

Bioorg Khim. 2011 Mar-Apr;37(2):223-32. Russian.

PMID:
21721255
[PubMed - indexed for MEDLINE]
9.

Use of the cardioprotectants thymosin β4 and dexrazoxane during congenital heart surgery: proposal for a randomized, double-blind, clinical trial.

Stromberg D, Raymond T, Samuel D, Crockford D, Stigall W, Leonard S, Mendeloff E, Gormley A.

Ann N Y Acad Sci. 2012 Oct;1270:59-65. doi: 10.1111/j.1749-6632.2012.06710.x.

PMID:
23050818
[PubMed - indexed for MEDLINE]
10.

Development of thymosin beta4 for treatment of patients with ischemic heart disease.

Crockford D.

Ann N Y Acad Sci. 2007 Sep;1112:385-95.

PMID:
17947592
[PubMed - indexed for MEDLINE]
11.

Controlled delivery of thymosin β4 for tissue engineering and cardiac regenerative medicine.

Chiu LL, Reis LA, Radisic M.

Ann N Y Acad Sci. 2012 Oct;1269:16-25. doi: 10.1111/j.1749-6632.2012.06718.x. Review.

PMID:
23045966
[PubMed - indexed for MEDLINE]
12.

Thymosin beta4 is cardioprotective after myocardial infarction.

Srivastava D, Saxena A, Michael Dimaio J, Bock-Marquette I.

Ann N Y Acad Sci. 2007 Sep;1112:161-70. Epub 2007 Jun 28.

PMID:
17600280
[PubMed - indexed for MEDLINE]
13.

The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure.

Jin H, Wyss JM, Yang R, Schwall R.

Curr Pharm Des. 2004;10(20):2525-33. Review.

PMID:
15320761
[PubMed - indexed for MEDLINE]
14.

Thymosin β4 protein therapy for cardiac repair.

Dubé KN, Bollini S, Smart N, Riley PR.

Curr Pharm Des. 2012;18(6):799-806. Review.

PMID:
22236126
[PubMed - indexed for MEDLINE]
15.

Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia.

Hinkel R, Bock-Marquette I, Hatzopoulos AK, Kupatt C.

Ann N Y Acad Sci. 2010 Apr;1194:105-11. doi: 10.1111/j.1749-6632.2010.05489.x. Erratum in: Ann N Y Acad Sci. 2010 Sep;1205(1):284. Hazopoulos, Antonis K [corrected to Hatzopoulos, Antonis K].

PMID:
20536456
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Treatment of neurological injury with thymosin β4.

Morris DC, Zhang ZG, Zhang J, Xiong Y, Zhang L, Chopp M.

Ann N Y Acad Sci. 2012 Oct;1269:110-6. doi: 10.1111/j.1749-6632.2012.06651.x. Review.

PMID:
23045978
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Thymosin β4 and cardiac protection: implication in inflammation and fibrosis.

Gupta S, Kumar S, Sopko N, Qin Y, Wei C, Kim IK.

Ann N Y Acad Sci. 2012 Oct;1269:84-91. doi: 10.1111/j.1749-6632.2012.06752.x. Review.

PMID:
23045975
[PubMed - indexed for MEDLINE]
18.

Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.

Smart N, Bollini S, Dubé KN, Vieira JM, Zhou B, Riegler J, Price AN, Lythgoe MF, Davidson S, Yellon D, Pu WT, Riley PR.

Ann N Y Acad Sci. 2012 Oct;1269:92-101. doi: 10.1111/j.1749-6632.2012.06708.x.

PMID:
23045976
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Epicardial progenitor cells in cardiac regeneration and neovascularisation.

Smart N, Dubé KN, Riley PR.

Vascul Pharmacol. 2013 Mar;58(3):164-73. doi: 10.1016/j.vph.2012.08.001. Epub 2012 Aug 11.

PMID:
22902355
[PubMed - indexed for MEDLINE]
20.

Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.

Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D.

Nature. 2004 Nov 25;432(7016):466-72.

PMID:
15565145
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk